Nasal vaccine innovation

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.18, Iss.10, 2010-12, pp. : 771-786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In situ gelling nasal inserts for influenza vaccine delivery

By Bertram Ulrike Bernard Marie-Clotilde Haensler Jean Maincent Philippe Bodmeier Roland

Drug Development and Industrial Pharmacy, Vol. 36, Iss. 5, 2010-05 ,pp. : 581-593

Informa Healthcare

Access to resources Recommend Favorite

Past Efforts and Future Prospects for a Nasal Influenza Vaccine

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 2, Iss. 1, 2015-06 ,pp. : 13-26

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicological Implications of Nasal Formulations

By Quadir Muhammad Zia Hossein Needham Thomas E.

Drug Delivery, Vol. 6, Iss. 4, 1999-10 ,pp. : 227-242

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Management of Nasal Polyposis

By Bachert Claus Watelet Jean-Baptiste Gevaert Philippe Paul Van Cauwenberge

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1537-1552

Adis International

Access to resources Recommend Favorite

Topical Corticosteroids in Nasal Polyposis

By Badia L. Lund V.

Drugs, Vol. 61, Iss. 5, 2001-01 ,pp. : 573-578

Adis International

Access to resources Recommend Favorite